1541171-67-8 (Carfilzomib Impurity 15,(αS)-α-2-(4-Morpholinyl)acetylaminobenzenebutanoyl-L-leucyl-N-(1S,3S)-4-chloro-3-hydroxy-3-methyl-1-(2-methylpropyl)-2-oxobutyl-L-phenylalaninamide)

卡非佐米杂质15;卡非左米杂质15;卡非佐米杂质W;卡非佐米杂质 9;

Carfilzomib Impurity 15;Carfilzomib Impurity 25;(S)-N-((S)-1-(((2S,4S)-1-Chloro-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide;PR-059428;L-Phenylalaninamide, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S,3S)-4-chloro-3-hydroxy-3-methyl-1-(2-methylpropyl)-2-oxobutyl]-;(αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S,3S)-4-chloro-3-hydroxy-3-methyl-1-(2-methylpropyl)-2-oxobutyl]-L-phenylalaninamide;Kyprolis Impurity W;Carfilzomib Impurity W;

ZGGLQLSTHZLELL-NZTKNTHTSA-N

1S/C40H58ClN5O7/c1-27(2)22-32(36(48)40(5,52)26-41)43-39(51)34(24-30-14-10-7-11-15-30)45-38(50)33(23-28(3)4)44-37(49)31(17-16-29-12-8-6-9-13-29)42-35(47)25-46-18-20-53-21-19-46/h6-15,27-28,31-34,52H,16-26H2,1-5H3,(H,42,47)(H,43,51)(H,44,49)(H,45,50)/t31-,32-,33-,34-,40+/m0/s1

[C@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@](O)(C)CCl)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN1CCOCC1)CCC1C=CC=CC=1)CC1C=CC=CC=1